Studies have demonstrated almost no Survivin expression in normal tissues but that Survivin is highly and selectively expressed in malignant tumors for most cancer types, including lung, liver, colon, pancreatic, prostate and breast cancers. This evidence concerns the gene BIRC5 and breast cancer.